Resonance Specialties Ltd-$
Resonance Specialties Ltd-$ (RESONANCE) last reported results for the quarter ended Jun 2026, with sales of ₹32.58 crore and net profit of ₹5.74 crore. The next scheduled event is a merger acquisition on 30 Nov 2026. The stock last traded at ₹187, a market capitalisation of ₹216 crore, on a P/E of 14.9. Over the past 52 weeks the stock has ranged between ₹77 and ₹201. Figures are as of 6 Oct 2026 and are not real time.
Resonance Specialties Ltd-$ share price and key metrics
- Current price
- ₹187
- Market cap
- ₹216 cr
- Stock P/E
- 14.9
- Book value
- ₹63.4
- ROE
- 15.0%
- ROCE
- 20.0%
- Dividend yield
- 0.53%
- 52w high / low
- 201/77.0
Metrics as of 6 Oct 2026. Not real time.
Track Resonance Specialties Ltd-$
Cruxal reads every Resonance Specialties Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Resonance Specialties Ltd-$ growth and returns
- 10 Years
- 9%
- 5 Years
- 5%
- 3 Years
- 16%
- TTM
- 24%
- 10 Years
- 24%
- 5 Years
- 0%
- 3 Years
- 27%
- TTM
- 92%
- 10 Years
- 17%
- 5 Years
- -4%
- 3 Years
- 27%
- 1 Year
- 90%
- 10 Years
- 14%
- 5 Years
- 13%
- 3 Years
- 11%
- Last Year
- 15%
Resonance Specialties Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹32.58 cr, up 53.2% from ₹21.27 cr a year earlier. Net profit was ₹5.74 cr, up 252.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 18.06 | 18.24 | 24.2 | 21.27 | 21.53 | 22.96 | 24.48 | 32.58 |
| Expenses | 15.71 | 16.35 | 19.95 | 18.72 | 19.17 | 19.51 | 18.84 | 25.12 |
| Operating profit | 2.35 | 1.89 | 4.25 | 2.55 | 2.36 | 3.45 | 5.64 | 7.46 |
| OPM % | 13.01% | 10.36% | 17.56% | 11.99% | 10.96% | 15.03% | 23.04% | 22.90% |
| Other income | 0.45 | 0.3 | 0.07 | 0.23 | 0.35 | 0.32 | 0.74 | 0.54 |
| Interest | 0.1 | 0.08 | 0.03 | 0.08 | 0.06 | 0.05 | 0.05 | 0.01 |
| Depreciation | 0.49 | 0.48 | 0.11 | 0.33 | 0.33 | 0.34 | 0.34 | 0.34 |
| Profit before tax | 2.21 | 1.63 | 4.18 | 2.37 | 2.32 | 3.38 | 5.99 | 7.65 |
| Tax % | 18.10% | 31.90% | 26.79% | 31.22% | 28.88% | 26.04% | 23.37% | 24.97% |
| Net profit | 1.81 | 1.12 | 3.06 | 1.63 | 1.66 | 2.51 | 4.6 | 5.74 |
| EPS (₹) | 1.57 | 0.97 | 2.65 | 1.41 | 1.44 | 2.17 | 3.98 | 4.97 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Resonance Specialties Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 36 | 41 | 56 | 70 | 76 | 58 | 55 | 78 | 90 | 102 |
| Operating profit | 2 | 1 | 5 | 8 | 14 | 17 | 7 | 5 | 11 | 14 | 19 |
| OPM % | 6% | 1.8% | 12% | 14% | 20% | 22% | 12% | 9% | 14% | 16% | 19% |
| Net profit | 1 | -1 | 3 | 6 | 11 | 12 | 5 | 3 | 7 | 10 | 15 |
| EPS (₹) | 0.89 | -0.67 | 2.77 | 4.77 | 9.11 | 10.71 | 4.33 | 2.57 | 5.69 | 9.01 | 12.56 |
TTM is the trailing twelve months to the most recent quarter.
Resonance Specialties Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 12 | 12 | 15 | 19 | 29 | 40 | 44 | 46 | 52 | 62 |
| Borrowings | 4 | 3 | 0 | 0 | 1 | 0 | 2 | 4 | 3 | 2 |
| Other liabilities | 12 | 10 | 12 | 11 | 13 | 5 | 8 | 12 | 8 | 17 |
| Total liabilities | 40 | 37 | 38 | 41 | 55 | 57 | 66 | 74 | 76 | 92 |
| Fixed assets | 15 | 15 | 14 | 14 | 16 | 14 | 20 | 23 | 21 | 21 |
| CWIP | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 4 |
| Investments | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 12 |
| Other assets | 25 | 22 | 23 | 25 | 38 | 42 | 45 | 48 | 54 | 57 |
| Total assets | 40 | 37 | 38 | 41 | 55 | 57 | 66 | 74 | 76 | 92 |
As reported by the company. Total assets equal total liabilities by construction.
Resonance Specialties Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1 | 2 | 5 | 1 | 4 | 13 | -8 | 4 | -3 | 17 |
| Cash from investing | -3 | -1 | -0 | -2 | -1 | -9 | 3 | -7 | 4 | -15 |
| Cash from financing | 2 | -1 | -4 | 1 | 0 | -2 | 1 | 0 | -1 | -2 |
| Net cash flow | -0 | 0 | 1 | 1 | 3 | 3 | -4 | -2 | -0 | -0 |
| Free cash flow | -2 | 1 | 5 | -1 | 3 | 13 | -16 | -0 | -4 | 14 |
| CFO / operating profit | 28% | 362% | 107% | 47% | 61% | 110% | -93% | 117% | -5% | 141% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Resonance Specialties Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 7% | 2% | 20% | 31% | 41% | 35% | 13% | 7% | 15% | 20% |
| Debtor days | 80 | 68 | 67 | 40 | 49 | 40 | 78 | 89 | 105 | 56 |
| Inventory days | 397 | 212 | 180 | 232 | 236 | 176 | 646 | 341 | 316 | 319 |
| Days payable | 262 | 127 | 139 | 114 | 121 | 17 | 138 | 134 | 65 | 113 |
| Cash conversion cycle | 215 | 152 | 108 | 158 | 164 | 198 | 587 | 295 | 356 | 263 |
| Working capital days | 85 | 80 | 93 | 82 | 99 | 143 | 212 | 221 | 206 | 156 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Resonance Specialties Ltd-$ shareholding pattern
Promoters held 54.25% at Jun 2026, broadly unchanged since Jun 2025. DIIs 1.55%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.25% | 54.25% | 54.25% | 54.25% | 54.25% | 54.25% | 54.25% | 54.25% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 1.55% |
| Public | 45.71% | 45.72% | 45.72% | 45.72% | 45.71% | 45.72% | 45.72% | 44.19% |
| No. of shareholders | 11,599 | 11,728 | 11,560 | 11,526 | 11,810 | 11,512 | 11,272 | 10,998 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Resonance Specialties Ltd-$ events
The next scheduled event is a merger acquisition on 30 Nov 2026.
- Merger acquisitionAcquisition of manufacturing facility from a related party
See the full results calendar for every Indian company reporting in the next 30 days.
Resonance Specialties Ltd-$ corporate filings
- Certificate under Reg 74(5)Company Updatelow impact
- Resonance Specialties Limited shareholders approve 29.98 crore acquisition of Kaygee Laboratories' manufacturing facilityAGM/EGMhigh impact
Cruxal's analysis: Resonance Specialties Limited has received shareholder approval via postal ballot for the…
Read the full analysis - the trading window for dealing in securities shall remain closed from close of business hours on September 30, 2026 and until 48 hours after the declaration of Company''s unaudited financial result.Insider Trading / SASTlow impact
- Resonance Specialties Limited receives reaffirmation of CRISIL BBB-/Stable credit rating for INR 14 crore bank facilitiesCompany Updatelow impact
Cruxal's analysis: Resonance Specialties Limited has announced that CRISIL has reaffirmed the long-term…
Read the full analysis - Resonance Specialties Ltd publishes newspaper notice for Postal Ballot and E-votingCompany Updatelow impact
Cruxal's analysis: Resonance Specialties Ltd has issued a newspaper notice regarding the Postal Ballot…
Read the full analysis - Resonance Specialties Limited to acquire manufacturing facility from related party Kaygee Laboratories for INR 29.98 croreAGM/EGMmedium impact
Cruxal's analysis: Resonance Specialties Limited has announced a postal ballot to seek shareholder approval…
Read the full analysis - Resonance Specialties Limited Reports Strong Q1 FY2027 Financial Results with Significant Revenue and Profit GrowthCompany Updatehigh impact
Cruxal's analysis: Resonance Specialties Limited reported robust financial results for the quarter ended…
Read the full analysis - Resonance Specialties Limited concludes 37th AGM with all six resolutions passed by requisite majorityAGM/EGMlow impact
Cruxal's analysis: Resonance Specialties Limited has successfully concluded its 37th Annual General Meeting…
Read the full analysis - Resonance Specialties Limited declares INR 1 per share dividend, approves related party transactions up to INR 40 crores at 37th AGMAGM/EGMmedium impact
Cruxal's analysis: Resonance Specialties Limited announced the proceedings of its 37th Annual General…
Read the full analysis - Resonance Specialties Ltd acquires manufacturing unit from Kaygee Laboratories Pvt LtdCompany Updatemedium impact
Cruxal's analysis: Resonance Specialties Ltd has announced the purchase of a manufacturing unit from Kaygee…
Read the full analysis - Resonance Specialties Reports Stellar Q1 FY27 Results with 252% PAT Growth, Acquires Key WHO-Approved Manufacturing Unit for INR 29.98 CroresResulthigh impact
Cruxal's analysis: Resonance Specialties Limited has delivered exceptionally strong financial results for Q1…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.